In conclusion, the present study demonstrated that the expression level of miR-27a was low in ESCC and that miR-27a directly targets the KRAS gene, resulting in inhibited cell proliferation in esophageal cancer. This evidence concerns the gene KRAS and esophageal squamous cell carcinoma.